Pharmacoinvasive Therapy With Prourokinase

NCT01642667 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

197

Enrollment

OTHER

Sponsor class

Conditions

ST-segment Elevation Myocardial Infarction (STEMI)

Interventions

DRUG: Prourokinase
DRUG: Placebo

Sponsor

Suzhou Landing Pharmaceuticals